Menu
Back to Journals » Cancer Management and Research » Volume 14
Original Research
Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,300 | Dovepress* | 6,720+ | 302 | 7,022 | |
| PubMed Central* | 580 | 107 | 687 | ||
| Totals | 7,300 | 409 | 7,709 | ||
| *Since 23 April 2022 | |||||
View citations on PubMed Central and Google Scholar